HAMP and inflammatory bowel disease: In one of the recent studies on newly diagnosed IBD patients, Stojkovic Lalosevic et al. suggested that hepcidin can be a reliable marker of iron deficiency anaemia in this group of patients, and it can be used in clinical practice to determinate adequate therapy.